Interesting..... AVXL news
Post# of 30028
Posted On: 03/17/2015 10:14:58 AM
NEW YORK, March 17, 2015 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company"
(AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer's and other central nervous system (CNS) diseases, pain and various types of cancer, today announces that Christopher U. Missling, PhD, president and chief executive officer, will participate in a clinical trials podium discussion titled, "Is there a way to increase the chance of success in Phase 3?" at the 12th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD 2015). The panel takes place on March 22, 2015 at 13:45 local time in the Apollon room of the Nice Acropolis Convention Center in Nice, France.
(AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer's and other central nervous system (CNS) diseases, pain and various types of cancer, today announces that Christopher U. Missling, PhD, president and chief executive officer, will participate in a clinical trials podium discussion titled, "Is there a way to increase the chance of success in Phase 3?" at the 12th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD 2015). The panel takes place on March 22, 2015 at 13:45 local time in the Apollon room of the Nice Acropolis Convention Center in Nice, France.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼